{
    "clinical_study": {
        "@rank": "163051", 
        "arm_group": [
            {
                "arm_group_label": "Ranolazine treatment", 
                "arm_group_type": "Experimental", 
                "description": "Ranolazine 500-1000mg bid"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "Working hypothesis and aims: 1) To explore the pathophysiology of postoperative troponin\n      elevations and 2) whether ranolazine, a new anti-ischemic drug that has no effect on blood\n      pressure or heart rate, prevents postoperative myocardial injury."
        }, 
        "brief_title": "Pathophysiology and Prevention of Perioperative Myocardial Injury: A Prospective Randomized Controlled Trial", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease,", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "High-risk patients undergoing non cardiac surgery will be randomized to receive either\n      Ranolazine or placebo perioperatively and troponin will be measured on the first 3 days\n      after surgery."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - All patients age 18 and above, undergoing major surgery that require at least 24 hours\n        (overnight) stay in the post anesthesia care unit (PACU) or intensive care unit (ICU), and\n        who either have known history of CAD or at least 3 of the following Revised Cardiac Risk\n        Index (RCRI) criteria29F17: 1) high-risk type of surgery, 2) history of ischemic heart\n        disease, 3) history of congestive heart failure, 4) history of cerebrovascular disease, 5)\n        diabetes mellitus, 6) renal failure (creatinine > 2mg/ml).\n\n        Exclusion Criteria:\n\n          -  Pregnancy, LV ejection fraction \u226435%, patients with severe valvular disease, patients\n             with poor echocardiographic images, patients who cannot swallow the pill after\n             surgery, refusal to participate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01810796", 
            "org_study_id": "HRanTrop"
        }, 
        "intervention": {
            "arm_group_label": "Ranolazine treatment", 
            "description": "Ranolazine versus placebo", 
            "intervention_name": "Ranolazine", 
            "intervention_type": "Drug", 
            "other_name": "Ranexa"
        }, 
        "intervention_browse": {
            "mesh_term": "Ranolazine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 13, 2013", 
        "location": {
            "contact": {
                "email": "gio@cc.huji.ac.il", 
                "last_name": "Giora Landesberg, Assoc. Prof.", 
                "phone": "97226777269"
            }, 
            "facility": {
                "address": {
                    "city": "Jerusalem", 
                    "country": "Israel", 
                    "zip": "91120"
                }, 
                "name": "Hadassah - Hebrew University Medical Center"
            }, 
            "investigator": {
                "last_name": "Giora Landesberg, Assoc. Prof.", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pathophysiology and Prevention of Perioperative Myocardial Injury: A Prospective Randomized Controlled Trial", 
        "overall_contact": {
            "email": "gio@cc.huji.ac.il", 
            "last_name": "Giora Landesberg, Assoc. Prof.", 
            "phone": "97226777269"
        }, 
        "overall_official": {
            "affiliation": "Hadassah Medical Organization", 
            "last_name": "Giora Landesberg, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ethics Commission", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Postoperative troponin", 
            "safety_issue": "Yes", 
            "time_frame": "3 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01810796"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hadassah Medical Organization", 
            "investigator_full_name": "Giora Landesberg", 
            "investigator_title": "Associate Profesor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Hadassah Medical Organization", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hadassah Medical Organization", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}